David Aaron Lehman - 01 Mar 2022 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role: General Counsel
Signature: /s/ David Lehman
Issuer symbol: LUNG
Transactions as of: 01 Mar 2022
Net transactions value: -$11,867
Form type: 4
Filing time: 03 Mar 2022, 17:11:01 UTC
Previous filing: 03 Dec 2021
Next filing: 03 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LUNG	Common Stock	Sale	$11,867	-458	-2.7%	$25.91	16,376	01 Mar 2022	Direct	F1
transaction	LUNG	Common Stock	Award	$0	+31,000	+189%	$0.000000	47,376	01 Mar 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LUNG	Employee Stock Option (right to buy)	Award	$0	+68,700		$0.000000	68,700	01 Mar 2022	Common Stock	68,700	$26.56	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.
F2	Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2022.
F3	The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2022.